Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Alternative Surveillance Program for Patients With High Risk Group of HCC [NA]

View source ↗

Summary

Clinical trial update describes an alternative surveillance program for high-risk hepatocellular carcinoma patients; the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING